Warning: The NCBI web site requires JavaScript to function. more...
Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo.
Wang YH, Liu S, Zhang G, Zhou CQ, Zhu HX, Zhou XB, Quan LP, Bai JF, Xu NZ.
Breast Cancer Res. 2005;7(2):R220-8. Epub 2004 Dec 17.
Related citations
Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth.
Parra E, Ferreira J.
Oncol Rep. 2010 Nov;24(5):1339-45.
Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
Breast Cancer Res Treat. 2009 Feb;113(3):443-56. Epub 2008 Mar 10.
Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells.
Yavari K, Taghikhani M, Ghannadi Maragheh M, Mesbah-Namin SA, Babaei MH.
Int J Colorectal Dis. 2010 Jan;25(1):9-16. Epub 2009 Aug 11.
Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
Zhang Y, Wang Y, Gao W, Zhang R, Han X, Jia M, Guan W.
Breast Cancer Res Treat. 2006 Apr;96(3):267-77. Erratum in: Breast Cancer Res Treat. 2007 May;103(1):129.
Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y, Xin XY, Chen BL, Ma X.
Pathology. 2006 Dec;38(6):561-7.
Knockdown of IGF-IR by RNAi inhibits SW480 colon cancer cells growth in vitro.
Yavari K, Taghikhani M, Maragheh MG, Mesbah-Namin SA, Babaei MH.
Arch Med Res. 2009 May;40(4):235-40.
[Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
Zhou CH, Peng XD, Wu J, Zhang P, Zhao ZR, Wei DP, Zhang CJ.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 May;39(3):373-7. Chinese.
The knockdown of c-myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo.
Zhang X, Ge YL, Tian RH.
Cell Mol Biol Lett. 2009;14(2):305-18. Epub 2009 Jan 28.
Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
Breast Cancer Res Treat. 2009 Sep;117(1):45-54. Epub 2008 Sep 13.
Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
Li J, Piao YF, Jiang Z, Chen L, Sun HB.
World J Gastroenterol. 2009 Jun 7;15(21):2602-8.
Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin.
Sun L, Cai L, Yu Y, Meng Q, Cheng X, Zhao Y, Sui G, Zhang F.
Acta Biochim Biophys Sin (Shanghai). 2007 Dec;39(12):999-1007.
C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
Venditti M, Iwasiow B, Orr FW, Shiu RP.
Int J Cancer. 2002 May 1;99(1):35-42.
Depletion of c-Myc inhibits human colon cancer colo 320 cells' growth.
Hongxing Z, Nancai Y, Wen S, Guofu H, Yanxia W, Hanju H, Qian L, Wei M, Yandong Y, Hao H.
Cancer Biother Radiopharm. 2008 Apr;23(2):229-37.
[Small interference RNAs directed against KDR gene inhibit the proliferation of breast cancer cells in vitro and in vivo].
Zhang XJ, Ge YL, Hou L, Li Q.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Jan;24(1):58-61. Review. Chinese.
[Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells: a study in tumor-bearing nude mice].
Wu WD, Fang CH, Yang ZX.
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jan;28(1):60-4. Chinese.
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.
Breast Cancer Res. 2007;9(6):R76.
The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y, San-Marina S, Yang L, Khoury H, Minden MD.
Breast Cancer Res. 2007;9(4):R43.
Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.
Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schütte J, Gardiner-Garden M, Ormandy CJ, McArthur G, Butt AJ, Sutherland RL.
PLoS One. 2008 Aug 20;3(8):e2987.
Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines.
Melkoumian ZK, Martirosyan AR, Strobl JS.
Int J Cancer. 2002 Nov 1;102(1):60-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on